article thumbnail

Clinical Trial Explores CBD’s Influence on Cannabis Safety

Veriheal

A randomized, double-blind, cross-over trial of cannabis recently published by Research Gate explored whether or not cannabidiol (CBD) — the primary non-intoxicating constituent of cannabis and hemp — improves or reduces the cannabis safety. . About the Study Into CBD’s Influence on Cannabis Safety.

article thumbnail

US Hemp Roundtable: NEW STUDY DEMONSTRATES CBD’S STRONG SAFETY PROFILE, AMPLIFIES CALLS FOR FDA REGULATION

Cannabis Law Report

Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. The results renew calls from the hemp and CBD industries urging FDA to take steps to regulate CBD now, and calling on Congress to act if FDA continues to delay. The methods for both phases were the same.

Safety 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

US Hemp Round Table: NEW STUDY DEMONSTRATES CBD’S STRONG SAFETY PROFILE, AMPLIFIES CALLS FOR FDA REGULATION

Cannabis Law Report

NEW STUDY DEMONSTRATES CBD’S STRONG SAFETY PROFILE , AMPLIFIES CALLS FOR FDA REGULATION. Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. I am very hopeful that this data will allow the FDA to regulate these popular CBD products.”.

Safety 52
article thumbnail

Largest Human Trial To Date Will Review Safety Of Full Spectrum Hemp Products

SpeedWeed

As is the case in the United States, Europe lacks sufficiently reliable scientific data to support the safety of products infused with full spectrum hemp extract. The post Largest Human Trial To Date Will Review Safety Of Full Spectrum Hemp Products appeared first on SpeedWeed. View original article.

Safety 52
article thumbnail

USHR Urges Congressional Action In Response To FDA’S Misguided Promotion Of Incomplete CBD Safety Data

Cannabis Law Report

Food and Drug Administration (FDA) webinar for hemp industry stakeholders, “A New Way Forward for Cannabidiol and Other Hemp Products,” U.S. Hemp Roundtable General Counsel, Jonathan Miller, wrote key congressional leaders alerting them […] On the heels of last week’s U.S.

Safety 52
article thumbnail

U.S. Hemp Roundtable Statement Regarding FDA NDIN Rejection Letters

Cannabis Law Report

Hemp Roundtable is deeply disappointed to witness FDA’s rejection of two dietary ingredient notifications (NDINs) recently submitted for full spectrum hemp extracts. (WASHINGTON) – The U.S. USHR-Statement-on-FDA-NDIN-Rejection-Letters.

Hemp 105
article thumbnail

4 Reasons Why Total Count Microbial Tests Are Poor Safety Indicators

Medicinal Genomics

Several articles have been published recently describing the challenges of microbial testing on cannabis and hemp. We believe a better way to ensure consumer safety is to perform species-specific tests that target known pathogenic organisms, such as A. One thing that all these articles have in common is total count tests. fumigatus, A.

Safety 92